Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

What Hedge Funds Think About The Andersons, Inc. (ANDE)

Page 1 of 2

At the moment, there are many methods shareholders can use to monitor their holdings. Two of the most innovative are hedge fund and insider trading interest. At Insider Monkey, our research analyses have shown that, historically, those who follow the best picks of the elite fund managers can outpace the broader indices by a very impressive margin (see just how much).

Equally as crucial, optimistic insider trading sentiment is another way to look at the marketplace. As the old adage goes: there are lots of reasons for a corporate insider to drop shares of his or her company, but only one, very clear reason why they would initiate a purchase. Several academic studies have demonstrated the impressive potential of this method if piggybackers know what to do (learn more here).

Keeping this in mind, it’s important to study the newest info about The Andersons, Inc. (NASDAQ:ANDE).

How are hedge funds trading The Andersons, Inc. (NASDAQ:ANDE)?

At the end of the second quarter, a total of 9 of the hedge funds we track were bullish in this stock, a change of -18% from one quarter earlier. With hedgies’ sentiment swirling, there exists an “upper tier” of notable hedge fund managers who were increasing their stakes substantially.

The Andersons, Inc. (NASDAQ:ANDE)According to our 13F database, Cliff Asness’s AQR Capital Management had the most valuable position in The Andersons, Inc. (NASDAQ:ANDE), worth close to $15.6 million, comprising 0.1% of its total 13F portfolio. On AQR Capital Management’s heels is SAC Capital Advisors, managed by Steven Cohen, which held a $9.2 million position; the fund has 0.1% of its 13F portfolio invested in the stock. Remaining hedge funds with similar optimism include D. E. Shaw’s D E Shaw, Paul Tudor Jones’s Tudor Investment Corp and Jim Simons’s Renaissance Technologies.

Since The Andersons, Inc. (NASDAQ:ANDE) has witnessed dropping sentiment from upper-tier hedge fund managers, it’s safe to say that there exists a select few fund managers that elected to cut their positions entirely at the end of the second quarter. It’s worth mentioning that Neil Chriss’s Hutchin Hill Capital dumped the biggest position of all the hedgies we track, worth an estimated $1.3 million in stock. John Overdeck and David Siegel’s fund, Two Sigma Advisors, also sold off its stock, about $0.6 million worth. These transactions are important to note, as aggregate hedge fund interest fell by 2 funds at the end of the second quarter.

How have insiders been trading The Andersons, Inc. (NASDAQ:ANDE)?

Bullish insider trading is most useful when the company we’re looking at has seen transactions within the past six months. Over the latest six-month time frame, The Andersons, Inc. (NASDAQ:ANDE) has experienced zero unique insiders buying, and zero insider sales (see the details of insider trades here).

We’ll go over the relationship between both of these indicators in other stocks similar to The Andersons, Inc. (NASDAQ:ANDE). These stocks are Chiquita Brands International, Inc. (NYSE:CQB), Calavo Growers, Inc. (NASDAQ:CVGW), Cresud S.A.C.I.F. y A. (ADR) (NASDAQ:CRESY), Fresh Del Monte Produce Inc (NYSE:FDP), and Adecoagro SA (NYSE:AGRO). This group of stocks are in the farm products industry and their market caps are closest to ANDE’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!